Altimmune (ALT) Cash from Restructuring (2015 - 2017)

Altimmune (ALT) posted quarterly Cash from Restructuring of -$66633.0 for Q1 2017, up 66.13% year-over-year from -$40109.6 in Q1 2016, and little changed quarter-over-quarter from -$66633.0 in Q4 2016.

Altimmune (ALT) Cash from Restructuring (2015 - 2017) Analysis & Trends

Altimmune (ALT) has reported Cash from Restructuring for 3 consecutive years, with -$66633.0 the latest figure, recorded in Q1 2017.

  • In Q1 2017, Cash from Restructuring rose 66.13% year-over-year to -$66633.0; the TTM figure through Mar 2017 stood at -$267300.0 (up 83.35% YoY), while the FY2016 annual figure was -$397383.0, down 182.49% from the prior year.
  • Cash from Restructuring held at -$66633.0 in Q1 2017 per ALT's latest filing, from -$66633.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $1.9 million in Q1 2015 and bottomed at -$1.1 million in Q2 2015.
  • Historically, Cash from Restructuring has averaged $7306.6 across 3 years, with a median of -$66727.0 in 2016.
  • On a YoY basis, Cash from Restructuring climbed as much as 93.93% in 2016 and fell as far as 762.99% in 2016.
  • Altimmune's Cash from Restructuring stood at -$319008.0 in 2015, then soared by 79.11% to -$66633.0 in 2016, then changed by 0.0% to -$66633.0 in 2017.
  • Business Quant data shows ALT's Cash from Restructuring at -$66633.0 in Q1 2017, -$66633.0 in Q4 2016, and -$67307.0 in Q3 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Altimmune 571.75 Mn 571.75 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2017 -66,633.00
Dec 31, 2016 -66,633.00
Sep 30, 2016 -67,307.00
Jun 30, 2016 -66,727.00
Mar 31, 2016 -196,716.00
Dec 31, 2015 -319,008.00
Sep 30, 2015 10,152.00
Jun 30, 2015 -1.10 Mn
Mar 31, 2015 1.94 Mn